In the case of SARS-CoV-2/HIV co-infection, we speculate that the elevated levels of VEGF-A observed in this clinical setting originate predominantly from activated immune cells because of upregulation of HIF-1α by damaged endothelial cells. This evidence concerns the gene VEGFA and coinfection.